April 17 (Reuters) - XINTELA AB:
* XINTELA DEVELOPS UNIQUE METHODS IN STEM CELL THERAPY FOR THE BRAIN AND BROADENS PATENT PORTFOLIO
* HAS DEVELOPED NEW METHODS FOR IDENTIFYING AND PURIFYING NEURAL STEM CELLS FROM BRAIN Source text for Eikon: Further company coverage: (Gdynia Newsroom)